Abeona Therapeutics Inc. (ABEO) by event type
ABEO moves most on rating reiterations — a median of +0.53% at 30 minutes across 41 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ABEO overview →
How ABEO reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,275 of 2,717 | 16 | -0.39% | 50% | -1.33% |
| Analyst downgrades 2,144 of 2,603 | 13 | -0.42% | 31% | -4.04% |
| Coverage initiations 1,894 of 2,283 | 15 | -0.47% | 13% | -1.31% |
| Rating reiterations 142 of 3,522 | 41 | +0.53% | 59% | +0.52% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how ABEO usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · ABEO overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Pacific Biosciences of California, Inc. (PACB) | 440 | -0.29% | 44% |
| EyePoint, Inc. (EYPT) | 439 | -0.25% | 46% |
| KalVista Pharmaceuticals, Inc. (KALV) | 438 | 0.00% | 50% |
| Zymeworks Inc. (ZYME) | 438 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.